Eun Ha
Nurse Practitioner · Santa Monica, CANPI 1215547484
Payments from drug & device makers
Across 164 payments — averaging $36.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Biogen$800
- AstraZeneca$784
- AbbVie$632
- Novartis$459
- UCB, Inc.$288
- plus $2K from 27 others
What the payments were for
- Travel & lodging$1,05718%
- Food & beverage$4,70079%
- Education$1713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 5 | $1,123 |
| Biogen | 18 | $800 |
| AstraZeneca(2 entities) | 14 | $784 |
| AbbVie(2 entities) | 25 | $632 |
| Novartis | 15 | $459 |
| UCB, Inc. | 12 | $288 |
| Neurocrine Biosciences, Inc. | 15 | $218 |
| SK Life Science, Inc. | 8 | $204 |
| Jazz Pharmaceuticals Inc. | 2 | $176 |
| Teva Pharmaceuticals USA, Inc. | 5 | $165 |
| Pfizer | 7 | $125 |
| Boston Scientific | 2 | $123 |
| Lundbeck LLC | 4 | $94 |
| Amgen | 3 | $84 |
| Neurelis, Inc. | 3 | $62 |
| Genentech USA, Inc. | 2 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Tanabe Pharma America, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| TG Therapeutics, Inc. | 1 | $32 |
| Grifols USA, LLC | 1 | $31 |
| Argenx US, Inc. | 1 | $31 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Adamas Pharmaceuticals, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| MDD US Operations, LLC | 1 | $17 |
| Sandoz | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,928 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 33 | $42,285 |
| UbrelvyUbrogepant | 11 | $16,915 |
| NeuproRotigotine | 12 | $15,824 |
| XcopriCenobamate | 11 | $12,817 |
| Tiagabine Hcl | 27 | $12,763 |
| Emgality PenGalcanezumab-Gnlm | 19 | $12,670 |
| EliquisApixaban | 12 | $11,688 |
| Rivastigmine | 27 | $5,326 |
| Levetiracetam | 42 | $2,409 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 53 | $2,298 |
| Memantine Hcl | 68 | $2,045 |
| Duloxetine Hcl | 18 | $1,829 |
| Rasagiline Mesylate | 13 | $1,491 |
| Oxcarbazepine | 16 | $1,384 |
| Donepezil Hcl | 119 | $1,082 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt, Eliquis | $125 | $53,97245 claims |
| AbbVieUbrelvy | $632 | $16,91511 claims |
| UCB, Inc.Neupro | $288 | $15,82412 claims |
| SK Life Science, Inc.Xcopri | $204 | $12,81711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Santa Monica
- Debbie TaySanta Monica$642K
- Lidia LopezSanta Monica$73K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.